Jean-Claude Leunis: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) m (Text replacement - " | first1" to "| first1") |
Notjusttired (talk | contribs) m (Text replacement - "8| pmid = " to "8 | pmid = ") |
||
| (56 intermediate revisions by the same user not shown) | |||
| Line 4: | Line 4: | ||
==Notable studies== | ==Notable studies== | ||
* 2021, The Reification of the Clinical Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) as an Immune and Oxidative Stress Disorder: Construction of a Data-Driven Nomothethic Network and Exposure of ME/CFS Subgroups<ref name="Maes2021">{{Cite journal|last=Maes|first=Michael| | * 2021, The Reification of the Clinical Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) as an Immune and Oxidative Stress Disorder: Construction of a Data-Driven Nomothethic Network and Exposure of ME/CFS Subgroups<ref name="Maes2021">{{Cite journal | last = Maes | first = Michael | authorlink = Michael Maes | last2 = Kubera | first2 = Marta | authorlink2 = | last3 = Stoyanova | first3 = Kristina | authorlink3 = | last4 = Leunis | first4 = Jean-Claude | authorlink4 = Jean-Claude Leunis | date = 2021-01-29 | title = The Reification of the Clinical Diagnosis of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) as an Immune and Oxidative Stress Disorder: Construction of a Data-Driven Nomothethic Network and Exposure of ME/CFS Subgroups | url = https://www.preprints.org/manuscript/202101.0623/v1|journal=Current Topics in Medicinal Chemistry|volume=21|issue=16|pages=1488-1499|doi=10.2174/1568026621666210727170147|pmc=|pmid=34315375|quote=|via=Preprints}}</ref> - [https://www.researchgate.net/publication/348868130_The_reification_of_the_clinical_diagnosis_of_myalgic_encephalomyelitis_chronic_fatigue_syndrome_MECFS_as_an_immune_and_oxidative_stress_disorder_construction_of_a_data-_driven_nomothethic_network_and_ (Full text)] | ||
*2014, Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome<ref name="Maes2014IBS">{{Cite journal|title=Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome|date=2014|url=https://pubmed.ncbi.nlm.nih.gov/25433843/|journal=Neuro Endocrinology Letters|volume=35|issue=6|pages=445–453|last=Maes|first=Michael| | *2014, Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome<ref name="Maes2014IBS">{{Cite journal | title = Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome | date = 2014 | url = https://pubmed.ncbi.nlm.nih.gov/25433843/|journal=Neuro Endocrinology Letters|volume=35|issue=6 | pages = 445–453 | last = Maes | first = Michael | authorlink = Michael Maes | last2 = Leunis | first2 = Jean-Claude | authorlink2 = Jean-Claude Leunis | last3 = Geffard | first3 = Michel | authorlink3 = | last4 = Berk | first4 = Michael | authorlink4 = Michael Berk|doi=|pmc=|pmid=25433843|access-date=|issn=0172-780X|quote=|via=}}</ref> - [https://www.nel.edu/userfiles/articlesnew/NEL350614A01.pdf (Full text)] | ||
*2011, Increased [[Immunoglobulin A|IgA]] responses to the LPS of commensal bacteria is associated with [[inflammation]] and activation of cell-mediated immunity in chronic fatigue syndrome<ref name="MaesM20111002">{{Cite journal | last1 | *2011, Increased [[Immunoglobulin A|IgA]] responses to the LPS of commensal bacteria is associated with [[inflammation]] and activation of cell-mediated immunity in chronic fatigue syndrome<ref name="MaesM20111002">{{Cite journal | last1 = Maes | first1 = Michael | authorlink1 = Michael Maes | last2 = Twisk | first2 = Frank N | authorlink2 = Frank Twisk | last3 = Kubera | first3 = M | authorlink3 = Marta Kubera | last4 = Ringel | first4 = K | authorlink4 = Karl Ringel | last5 = Leunis | first5 = JC | authorlink5 = Jean-Claude Leunis | last6 = Geffard | first6 = M | authorlink6 = Michel Geffard| title = Increased IgA responses to the LPS of commensal bacteria is associated with inflammation and activation of cell-mediated immunity in chronic fatigue syndrome| journal = J Affect Disord | volume = 136 | issue =3 | pages = 909-17 | url = https://pubmed.ncbi.nlm.nih.gov/21967891 | date = Oct 2, 2011 | pmid = 21967891 | doi = 10.1016/j.jad.2011.09.010 }}</ref> - [https://pubmed.ncbi.nlm.nih.gov/21967891 (Abstract)] | ||
*2008, Normalization of [[Intestinal permeability|leaky gut]] in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: Effects of age, duration of illness and the translocation of LPS from gram-negative bacteria<ref name="Maes, 2008">{{Cite journal | last1 | *2008, Normalization of [[Intestinal permeability|leaky gut]] in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: Effects of age, duration of illness and the translocation of LPS from gram-negative bacteria<ref name="Maes, 2008">{{Cite journal | last1 = Maes | first1 = Michael | authorlink1 = Michael Maes | last2 = Leunis | first2 = JC | authorlink2 = Jean-Claude Leunis| title = Normalization of leaky gut in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: Effects of age, duration of illness and the translocation of LPS from gram-negative bacteria| journal = Neuro endocrinology letters | volume = 26 | issue = 6 | pages = 902-910| url = https://pubmed.ncbi.nlm.nih.gov/19112401 | date = 2008 | pmid = 19112401 }}</ref> - [https://www.researchgate.net/publication/23709068_Normalization_of_leaky_gut_in_chronic_fatigue_syndrome_CFS_is_accompanied_by_a_clinical_improvement_Effects_of_age_duration_of_illness_and_the_translocation_of_LPS_from_gram-negative_bacteria (Abstract)]*2006, Increased serum [[Immunoglobulin A|IgA]] and [[Immunoglobulin M|IgM]] against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability.<ref name="MaesM20060927">{{Cite journal | last = Maes | first1 = Michael | authorlink1 = Michael Maes | last2 = Mihaylova | first2 = Ivanka | authorlink2 = Ivanka Mihaylova | last3 = Leunis | first3 = JC | authorlink3 = Jean-Claude Leunis| title = Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability| journal = J Affect Disord | volume = 99 |issue = 1-3| pages = 237-240 | url = https://doi.org/10.1016%2Fj.jad.2006.08.021 | date = Sep 27, 2006 | pmid = 17007934 | doi = 10.1016/j.jad.2006.08.021}}</ref> - [https://doi.org/10.1016%2Fj.jad.2006.08.021 (Abstract)] | ||
==Clinic location== | ==Clinic location== | ||
Latest revision as of 03:15, April 2, 2023
 | This article is a stub. |
Jean-Claude Leunis is a researcher in Belgium.
Notable studies[edit | edit source]
- 2021, The Reification of the Clinical Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) as an Immune and Oxidative Stress Disorder: Construction of a Data-Driven Nomothethic Network and Exposure of ME/CFS Subgroups[1] - (Full text)
- 2014, Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome[2] - (Full text)
- 2011, Increased IgA responses to the LPS of commensal bacteria is associated with inflammation and activation of cell-mediated immunity in chronic fatigue syndrome[3] - (Abstract)
- 2008, Normalization of leaky gut in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: Effects of age, duration of illness and the translocation of LPS from gram-negative bacteria[4] - (Abstract)*2006, Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability.[5] - (Abstract)
Clinic location[edit | edit source]
Talks and interviews[edit | edit source]
Online presence[edit | edit source]
- PubMed
- Website
- YouTube
- Address: clinic/lab-address
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ Maes, Michael; Kubera, Marta; Stoyanova, Kristina; Leunis, Jean-Claude (January 29, 2021). "The Reification of the Clinical Diagnosis of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) as an Immune and Oxidative Stress Disorder: Construction of a Data-Driven Nomothethic Network and Exposure of ME/CFS Subgroups". Current Topics in Medicinal Chemistry. 21 (16): 1488–1499. doi:10.2174/1568026621666210727170147. PMID 34315375 – via Preprints.
- ↑ Maes, Michael; Leunis, Jean-Claude; Geffard, Michel; Berk, Michael (2014). "Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome". Neuro Endocrinology Letters. 35 (6): 445–453. ISSN 0172-780X. PMID 25433843.
- ↑ Maes, Michael; Twisk, Frank N; Kubera, M; Ringel, K; Leunis, JC; Geffard, M (October 2, 2011). "Increased IgA responses to the LPS of commensal bacteria is associated with inflammation and activation of cell-mediated immunity in chronic fatigue syndrome". J Affect Disord. 136 (3): 909–17. doi:10.1016/j.jad.2011.09.010. PMID 21967891.
- ↑ Maes, Michael; Leunis, JC (2008). "Normalization of leaky gut in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: Effects of age, duration of illness and the translocation of LPS from gram-negative bacteria". Neuro endocrinology letters. 26 (6): 902–910. PMID 19112401.
- ↑ Maes, Michael; Mihaylova, Ivanka; Leunis, JC (September 27, 2006). "Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability". J Affect Disord. 99 (1–3): 237–240. doi:10.1016/j.jad.2006.08.021. PMID 17007934.
